FLAZONEXAR 137mcg/50mcg/dose nasal spray, suspension SIGILLATA
Active substance: azelastine + fluticasone
Indicated for: allergic rhinitis
Find medicines for human use by name or active substance.
Browse by initial
401–420 of 836 medicines
Active substance: azelastine + fluticasone
Indicated for: allergic rhinitis
Active substance: diosmin
C05CA03 Cardiovascular system | Capillary stabilizing agents | Bioflavonoids
Indicated for: chronic venous insufficiency; capillary fragility
Active substance: diosmin
C05CA03 Cardiovascular system | Capillary stabilizing agents | Bioflavonoids
Indicated for: chronic venous insufficiency; capillary fragility
Active substance: hydrocortisone
Indicated for: inflammation; adrenal insufficiency
Active substance: normal immunoglobulin for intravascular administration
J06BA02 Antiinfectives for systemic use | Immunoglobulins | Immunoglobulins, normal human
Indicated for: immunosuppression
Active substance: normal immunoglobulin for intravascular administration
J06BA02 Antiinfectives for systemic use | Immunoglobulins | Immunoglobulins, normal human
Indicated for: immunosuppression
Active substance: normal immunoglobulin for intravascular administration
J06BA02 Antiinfectives for systemic use | Immunoglobulins | Immunoglobulins, normal human
Indicated for: immunosuppression
Active substance: normal immunoglobulin for intravascular administration
J06BA02 Antiinfectives for systemic use | Immunoglobulins | Immunoglobulins, normal human
Indicated for: immunosuppression
Active substance: levofloxacin
J01MA12 Antiinfectives for systemic use | Quinolone antibacterials | Fluoroquinolones
Indicated for: bacterial infections
Active substance: levofloxacin
J01MA12 Antiinfectives for systemic use | Quinolone antibacterials | Fluoroquinolones
Indicated for: bacterial infections
Active substance: diosmin
C05CA03 Cardiovascular system | Capillary stabilizing agents | Bioflavonoids
Indicated for: chronic venous insufficiency; capillary fragility
Active substance: St. John's wort
Indicated for: herbal symptomatic treatment
Active substance: glucosamine
Indicated for: osteoarthritis; degenerative joint disorders
Active substance: infliximab
Indicated for: inflammatory bowel disease
Active substance: fluticasone propionate
Indicated for: asthma; chronic obstructive pulmonary disease
Active substance: fluticasone propionate
Indicated for: asthma; chronic obstructive pulmonary disease
WHO (World Health Organization): Any substance or product that is used or is intended to be used to alter a physiological system or a pathological condition in the recipient's benefit.
Medicinal product: A substance or combination of substances used to treat or prevent disease, to restore, correct or modify physiological functions through pharmacological, immunological or metabolic action, or to make a medical diagnosis.
Active ingredient: A substance used in a medicine to produce a pharmacological, immunological or metabolic effect that restores, corrects or modifies physiological functions.
Excipients: Ingredients in a medicine other than its active substance. They can help stabilise the medicine or deliver the active substance to its intended site of action.
Original medicine: A medicine first authorised on the basis of a full dossier documenting its quality, safety and efficacy. It may serve as the reference medicine for a generic product.
Generic medicine: A medicine developed to be equivalent to an authorised reference medicine. It contains the same active substance or substances and is used at the same doses to treat the same diseases. Its inactive ingredients, name, appearance and packaging may differ.